CTXND2
geneOn this page
Summary
CTXND2 (cortexin domain containing 2, HGNC:53440) is a protein-coding gene on chromosome 1q21.3, encoding Cortexin domain containing 2 (A0A1B0GV90).
Predicted to be located in membrane.
Source: NCBI Gene 100996521 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001384189
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53440 |
| Approved symbol | CTXND2 |
| Name | cortexin domain containing 2 |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000283324 |
| Ensembl biotype | protein_coding |
| Entrez | 100996521 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000636087
RefSeq mRNA: 1 — MANE Select: NM_001384189
NM_001384189
CCDS: CCDS91049
Canonical transcript exons
ENST00000636087 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003791748 | 150887136 | 150887313 |
| ENSE00003793610 | 150912242 | 150913292 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 82.72.
Top tissues by expression
109 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.72 | gold quality |
| right uterine tube | UBERON:0001302 | 55.51 | gold quality |
| placenta | UBERON:0001987 | 49.28 | gold quality |
| fallopian tube | UBERON:0003889 | 43.29 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.46 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.73 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.27 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| apex of heart | UBERON:0002098 | 36.39 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| endometrium | UBERON:0001295 | 34.86 | gold quality |
| bone marrow | UBERON:0002371 | 34.22 | gold quality |
| muscle tissue | UBERON:0002385 | 33.92 | silver quality |
| primary visual cortex | UBERON:0002436 | 33.78 | gold quality |
| corpus callosum | UBERON:0002336 | 33.57 | gold quality |
| mucosa of stomach | UBERON:0001199 | 33.42 | gold quality |
| vermiform appendix | UBERON:0001154 | 32.80 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| blood | UBERON:0000178 | 31.32 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| tonsil | UBERON:0002372 | 30.83 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 30.79 | gold quality |
| testis | UBERON:0000473 | 30.59 | gold quality |
| liver | UBERON:0002107 | 30.50 | gold quality |
| monocyte | CL:0000576 | 30.47 | gold quality |
| left testis | UBERON:0004533 | 30.44 | silver quality |
| right testis | UBERON:0004534 | 30.40 | silver quality |
| gastrocnemius | UBERON:0001388 | 30.25 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ctxnd2 | ENSMUSG00000105734 |
Protein
Protein identifiers
Cortexin domain containing 2 — A0A1B0GV90 (reviewed: A0A1B0GV90)
All UniProt accessions (1): A0A1B0GV90
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
RefSeq proteins (1): NP_001371118* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020066 | Cortexin | Family |
Pfam: PF11057
UniProt features (2 total): chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GV90-F1 | 80.14 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
chr1q21, SIX1_TARGET_GENES, CC2D1A_TARGET_GENES, ZSCAN4_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
22 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CTXND2 | C1orf141 | Q5JVX7 | 349 |
| CTXND2 | TMEM210 | A6NLX4 | 349 |
| CTXND2 | SMIM9 | A6NGZ8 | 347 |
| CTXND2 | SMIM8 | Q96KF7 | 304 |
| CTXND2 | SLC25A41 | Q8N5S1 | 248 |
| CTXND2 | SLC35D1 | Q9NTN3 | 209 |
| CTXND2 | CBY2 | Q8NA61 | 205 |
| CTXND2 | SLC35D2 | Q76EJ3 | 183 |
| CTXND2 | RASEF | Q8IZ41 | 180 |
| CTXND2 | TOMM20L | Q6UXN7 | 155 |
| CTXND2 | TOMM20 | Q15388 | 155 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GQX3, A0A1B0GRQ0, A0A1B0GV90, A4D0T7, A4QNL6, A6NFZ4, A9RA88, B0CMA4, B3DHH5, C0HJJ0, C1PGW0, D3YUK8, F2Z3Y9, F5HFG3, G1TZA0, G2TRP0, O13001, O14068, O39920, P0DKX4, P34535, P57054, P61807, P61808, Q06FW7, Q19443, Q3E8L0, Q3E912, Q3T0S0, Q4V921, Q54L98, Q5F3W2, Q5R687, Q5RBD8, Q5U4Q2, Q66J27, Q6PQZ3, Q80UA9, Q80ZU4, Q8AUU1
Diamond homologs: A0A1B0GQX3, A0A1B0GST9, A0A1B0GTU2, A0A1B0GV90, P0C2S0, P41237, P60606, Q3URE8, Q4LDR2, Q8K129
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
354 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:150912417:T:C | C35R | 0.964 |
| 1:150912364:C:A | A17D | 0.935 |
| 1:150912382:T:G | L23R | 0.928 |
| 1:150912391:T:G | L26R | 0.927 |
| 1:150912397:T:G | L28R | 0.927 |
| 1:150912385:T:G | L24R | 0.918 |
| 1:150912397:T:C | L28P | 0.917 |
| 1:150912370:C:A | A19D | 0.905 |
| 1:150912415:G:C | R34P | 0.899 |
| 1:150912406:T:G | M31R | 0.892 |
| 1:150912419:T:G | C35W | 0.888 |
| 1:150912379:T:A | V22D | 0.886 |
| 1:150912376:T:A | V21D | 0.884 |
| 1:150912385:T:C | L24P | 0.876 |
| 1:150912400:T:A | I29K | 0.870 |
| 1:150912351:G:C | D13H | 0.869 |
| 1:150912357:G:C | G15R | 0.869 |
| 1:150912382:T:A | L23H | 0.864 |
| 1:150912406:T:A | M31K | 0.861 |
| 1:150912352:A:T | D13V | 0.859 |
| 1:150912358:G:A | G15D | 0.850 |
| 1:150912418:G:A | C35Y | 0.850 |
| 1:150912420:G:C | A36P | 0.849 |
| 1:150912363:G:C | A17P | 0.848 |
| 1:150912372:T:C | F20L | 0.830 |
| 1:150912374:T:A | F20L | 0.830 |
| 1:150912374:T:G | F20L | 0.830 |
| 1:150912427:T:C | L38P | 0.827 |
| 1:150912400:T:G | I29R | 0.822 |
| 1:150912391:T:A | L26Q | 0.821 |
dbSNP variants (sampled 300 via entrez): RS1000048275 (1:150901106 T>C), RS1000445602 (1:150897327 A>G), RS1000568984 (1:150889003 C>A,T), RS1000600159 (1:150908261 T>C,G), RS1000625134 (1:150901595 A>G), RS1000699580 (1:150907256 G>A), RS1000702921 (1:150890645 A>C,G), RS1000932089 (1:150897607 C>A), RS1000999532 (1:150902366 C>T), RS1001248075 (1:150889261 G>A), RS1001288629 (1:150900206 T>C), RS1001360504 (1:150896706 A>C,G), RS1001362920 (1:150904120 C>T), RS1001416829 (1:150904478 TA>T), RS1001443079 (1:150901838 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs12410394 | ARNT, CTXND2 | 0.00 | 0 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.